How stopping GLP-1 weight-loss drugs may raise risk of stroke or heart attack

South China Morning Post - Nov 20, 2026

Weight-loss drugs help people shed weight, protecting them from strokes and heart attacks. But many people gain weight again after stopping taking GLP-1 receptor agonists such as semaglutide (including trade names Ozempic and Wegovy) and tirzepatide (Mounjaro). For type 2 diabetes patients, the risk of serious cardiovascular events and death increases significantly once they stop treatment, according to a study published in The Lancet Regional Health Europe. About 80,000 people with type 2...

Read full article

More News

Voyage Times

Voyage Times publishes travel and lifestyle articles for travelers and culture hunter from around the world. Discover the places that you haven't heard of here.

NEWSLETTER

Copyright © 2015 - 2026 Voyage Times. All Rights Reserved.